Vizgen and Ultivue, two companies at the forefront of developing technologies that allow scientists to map the ...
The Centers for Medicare and Medicaid Services on Wednesday published a list of 101 commonly used generic medicines that ...
With a new presidential administration next year, FDA Principal Deputy Commissioner Namandjé Bumpus would be in line to lead ...
GSK said Wednesday that it is paying up to $2.2 billion to resolve 93% of its US state-based liability cases related to its ...
The three major PBMs being sued by the FTC have filed motions to disqualify the Democratic commissioners who would rule on ...
Artificial intelligence has its Nobel Prize moment. On Tuesday, the Nobel Prize in Physics went to a pair of longtime AI ...
Thera, Richter, InnoCare and Scholar Rock: Crinetics prices $500M offering: The San Diego biotech upsized the offering by $100 million from $400 million. The biotech last month asked the FDA to ...
The FDA handed down a second complete response letter to Zealand Pharma for its glucagon receptor agonist in an ultra-rare ...
Clearside Biomedical reported positive results from a Phase 2b trial of its tyrosine kinase inhibitor in patients with wet ...
This year's prestigious Nobel Prize in Chemistry has been awarded to David Baker, the director of the Institute for Protein ...
If all goes according to plan, insitro could finally start testing its first drug in clinical trials in 2026, eight years ...
Concentra Biosciences, a shell company from Tang Capital, wants to buy another biotech that has found itself in a bind. Kevin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback